Cellebrite DI Ltd. (CLBT) Bundle
At a current intraday quote of $18.97 (change -$0.27 / -0.01%) with an open of $19.24, a high of $19.37, a low of $18.88 and volume at 194,610 (latest trade Tuesday, Dec 23, 09:14:33 PST), Cellebrite DI Ltd. (CLBT) is drawing fresh attention as institutional ownership climbs to 53.9% as of September 2025 (up from 49.4% in June), led by True Wind Capital Management's 5.77% stake and T. Rowe Price's notable position after boosting holdings by 107.82% to 6.52 million shares, while Connors Investor Services hiked its stake by 26.6% in Q2 2025 - data points that dovetail with a Moderate Buy analyst consensus and a $21.75 12‑month target, a strategic acquisition (Corellium, June 2025) and robust fundamentals including a 23% ARR increase to $408 million in Q1 2025 that together explain why investors are piling in and what to watch next.
Cellebrite DI Ltd. (CLBT) - Who Invests in Cellebrite DI Ltd. (CLBT) and Why?
Cellebrite DI Ltd. (CLBT) intraday snapshot:| Metric | Value |
|---|---|
| Last Price | 18.97 USD |
| Change | -0.27 USD (-0.01%) |
| Latest Open | 19.24 USD |
| Intraday High | 19.37 USD |
| Intraday Low | 18.88 USD |
| Intraday Volume (so far) | 194,610 |
| Latest Trade Time | Tuesday, December 23, 09:14:33 PST |
- Institutional investors: Pension funds, asset managers and hedge funds are core holders-driven by growth prospects in digital intelligence, recurring software revenue and multinational customer contracts.
- Long-only growth investors: Attracted by the recurring revenue model, high gross margins on software sales and cross-sell opportunities into law enforcement and enterprise security.
- Value / event-driven traders: Participate around results, contract announcements, and M&A speculation; these traders often target intraday volatility (note the current intraday volume of 194,610).
- Retail investors: Drawn to the security/forensics narrative and headline deals; retail interest often spikes on product news or earnings beats.
| Signal / Metric | Typical Range / Note |
|---|---|
| Institutional ownership (typical post-IPO tech) | ~50%-75% (varies by reporting period) |
| Float concentration | Moderate - several large funds and insiders often hold significant blocks |
| Average daily volume (recent months) | Can range from ~0.5M to 3M shares depending on news cycle |
| Volatility drivers | Quarterly revenue results, major government/enterprise contracts, regulatory/privacy developments |
- Institutional: Portfolio diversification into cybersecurity/digital-forensics with recurring revenue and enterprise contracts.
- Growth investors: Revenue growth acceleration, higher ARR, and margin expansion potential.
- Event-driven traders: Short-term alpha from contract announcements, earnings surprises and guidance revisions.
- Retail: Story-driven momentum and accessible share price for smaller accounts.
- Revenue composition: SaaS / recurring vs. one-time device sales
- ARR growth rate and retention metrics
- Gross margin trends and operating leverage
- Contract wins with government and enterprise customers (size, duration)
- Cash flow and balance sheet strength versus capital expenditure needs
Institutional Ownership and Major Shareholders of Cellebrite DI Ltd. (CLBT)
Cellebrite DI Ltd. (CLBT) has attracted a diverse investor base driven by recurring-revenue strength, strategic M&A, and a favorable analyst outlook. Institutional investors account for approximately 53.9% of CLBT's shares as of September 2025, signaling broad professional confidence in the company's growth trajectory.- Institutional ownership: ~53.9% (Sept 2025)
- True Wind Capital Management, L.P.: 5.77% stake
- T. Rowe Price Investment Management, Inc.: 3.53 million shares held
- Connors Investor Services Inc.: stake increased by 26.6% in Q2 2025
- Analyst consensus: 'Moderate Buy' - 12‑month price target $21.75
| Shareholder | Position / Data | Notable Note |
|---|---|---|
| Institutional Investors (aggregate) | 53.9% of shares | Majority professional ownership |
| True Wind Capital Management, L.P. | 5.77% stake | Top named institutional holder |
| T. Rowe Price Investment Management, Inc. | 3.53 million shares | Large, diversified asset manager |
| Connors Investor Services Inc. | Stake ↑ 26.6% (Q2 2025) | Recent accumulation signals increasing interest |
| Other institutions / funds | Remainder of institutional ~53.9% | Collective positions across multiple managers |
- ARR (Q1 2025): $408 million (+23% year-over-year)
- Strategic M&A: Corellium acquisition (June 2025)
- Analyst 12‑month price target: $21.75 - consensus 'Moderate Buy'
Cellebrite DI Ltd. (CLBT) - Key Investors and Their Impact on Cellebrite DI Ltd. (CLBT)
Institutional ownership has risen sharply into September 2025, signaling greater confidence from professional investors in Cellebrite DI Ltd. (CLBT). Key measurable shifts are driving liquidity, governance influence, and the market narrative around CLBT's growth trajectory.- Institutional ownership: 53.9% (Sep 2025), up from 49.4% (Jun 2025).
- Number of institutional investors: 195 firms, a 20.37% year-over-year increase.
- Largest institutional holder: True Wind Capital Management, L.P. - 5.77% of shares.
- T. Rowe Price Investment Management, Inc.: increased holdings by 107.82% to 6.52 million shares.
- Other notable institutional holders include Invesco Advisers, Inc. and Pertento Partners LLP (significant, diversified stakes).
| Investor | % of Outstanding Shares | Shares Held | Recent Change |
|---|---|---|---|
| True Wind Capital Management, L.P. | 5.77% | Data report: proportionate stake | Largest institutional stake (reported) |
| T. Rowe Price Investment Management, Inc. | N/A | 6.52M | Holdings up 107.82% |
| Invesco Advisers, Inc. | N/A | N/A | Significant institutional stake |
| Pertento Partners LLP | N/A | N/A | Material holding; part of diversified investor base |
| All institutions (aggregate) | 53.9% | 195 institutional holders | Institutional count +20.37% YoY; ownership +4.5ppt since Jun 2025 |
- Improved liquidity and deeper trading volumes from professional desks and fund managers.
- Greater scrutiny and governance pressure, aligning management incentives with long-term performance.
- Potential for strategic support (follow-on funding, sell-side coverage, analyst engagement).
- Higher share stability during retail-driven volatility due to larger, longer-term positions.
Cellebrite DI Ltd. (CLBT) - Market Impact and Investor Sentiment
Cellebrite DI Ltd. (CLBT) has attracted a mix of activist, long-only, and diversified institutional investors whose holdings and recent activity are materially shaping market perception, liquidity, and capital access for strategic initiatives. Institutional concentration combined with fresh buying has tightened the narrative around confidence in CLBT's product-led growth, M&A optionality, and recurring revenue expansion.- True Wind Capital Management, L.P. - reported holding 5.77% of outstanding shares, a meaningful position that signals conviction in management's strategic direction and provides potential activist influence on corporate strategy.
- T. Rowe Price Investment Management, Inc. - identified as a substantial institutional holder, reinforcing long-term growth expectations among large-cap-active managers and stabilizing shareholder base.
- Connors Investor Services Inc. - increased its stake by 26.6% in Q2 2025, reflecting accelerating confidence in CLBT's near-term financial trajectory and signaling momentum to other investors.
- Invesco Advisers, Inc. and Pertento Partners LLP - additions that broaden the investor mix, reducing single-holder concentration risk and improving market depth.
| Investor | Reported Position / Change | Likely Market Impact |
|---|---|---|
| True Wind Capital Management, L.P. | 5.77% of shares | Higher governance influence; potential catalyst for strategic review or targeted initiatives |
| T. Rowe Price Investment Management, Inc. | Substantial institutional stake (top-tier active manager) | Signals long-term growth conviction; stabilizes institutional ownership |
| Connors Investor Services Inc. | 26.6% increase in stake in Q2 2025 | Momentum signal to market; may attract momentum-driven funds and analysts' attention |
| Invesco Advisers, Inc. | Institutional investment (diversified fund exposure) | Enhances liquidity and market stability |
| Pertento Partners LLP | Private/partner stake supporting strategic alignment | Provides patient capital; supports long-term initiatives |
- Collective capital: these investors collectively supply equity demand and capital that reduce dilution risk for future raises and enable funding for product R&D, sales expansion, and targeted acquisitions.
- Investor signaling: visible increases (e.g., Connors' +26.6% in Q2 2025) and concentrated positions (e.g., True Wind's 5.77%) improve investor sentiment and can narrow implied volatility as markets price reduced downside risk from uncertain ownership.
- Diversification effect: the mix of activist, growth-oriented, and diversified institutional holders mitigates single-strategy exits and supports a steadier share-price response to corporate news.

Cellebrite DI Ltd. (CLBT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.